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INTRODUCTION 
 
Cancer in children differs from cancer in adults. The leading cancers that occur in adults are 
carcinomas, such as breast, prostate, bronchus and lung, and colorectal (1).  These cancers arise 
from the tissues that line the internal and external surfaces of the body.  The leading cancers that 
occur in children are leukemia, lymphomas, and central nervous system cancers (2).  In addition, 
some of the risk factors for childhood cancers may differ from risk factors for adult cancers.  
Genetic factors and prenatal exposures may increase the risk of developing childhood cancer, as 
well as environmental, parental occupational, and medical factors (3).  Because of these 
differences, this report focuses on childhood cancer in Massachusetts.  A specific coding 
scheme, the International Classification of Childhood Cancer (ICCC), has been devised to group 
childhood cancers. The ICCC groups cancers primarily by morphology (form or structure) rather 
than site as in adult cancer (4). 
 
Childhood Cancer in Massachusetts is specifically devoted to providing information about 
childhood cancers that occur in children (0-14 years) and adolescents (15-19 years).  First, the 
report details statewide patterns of childhood cancer between 1990 and 1999, including trends in 
the incidence of childhood cancer, the most common childhood cancers at various ages, and rates 
of childhood cancer by race/ethnicity.  Next, the report provides more detailed information on 
childhood cancer incidence by ICCC grouping, including trends over time and comparisons by 
age groups.  The report briefly covers statewide patterns of childhood cancer mortality between 
1990 and 1998.  Finally, the appendices of the report show coding classifications and detailed 
tables on childhood cancer incidence and mortality. 
 
 
METHODS 
 
Data Sources 
 
Cancer Incidence  
 
Massachusetts cancer incidence data are collected by the Massachusetts Cancer Registry (MCR).  
The MCR is a population based cancer registry, established by state law in 1980, that collects 
reports of all newly diagnosed cancer cases from all Massachusetts acute care hospitals and one 
medical practice association that maintains a cancer registry. The MCR collects information on 
in situ and invasive cancers, except basal and squamous cell carcinomas of the skin, and benign 
tumors of the brain and associated tissues.  
 
The activities of the MCR involve data collection efforts that necessitate extensive interaction 
with hospital tumor registrars.  Intensive data evaluation is also required to ensure data quality.  
The fundamental requirements of any central cancer registry include: a) complete registration, 
b) prevention of duplication, c) collection of uniform data (i.e., standardization of items, 
definitions, rules, classification and nomenclature of primary site, histology, staging and 
procedures), d) quality control and e) efficient data processing. 
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MCR case ascertainment improved during the years covered by this report as additional case 
sources became available.  For all diagnosis years, the MCR collects incident case information 
from diagnosing hospitals and hospitals providing initial treatment.  For diagnosis year 1995 and 
onward, the MCR collects information from reporting hospitals on cases diagnosed and initially 
treated at other facilities, but receiving subsequent therapy or being diagnosed or treated for the 
cancer’s progression or recurrence at the reporting facility.  For diagnosis year 1996 and onward, 
the MCR collects information from reporting hospitals on cases diagnosed and treated in staff 
physician offices, when this information is available.  However, not all hospitals report this type 
of case because reporting is optional for physician office only cases.  Most cases of childhood 
cancer would not be diagnosed or treated solely in staff physician offices so this source of cases 
does not greatly affect childhood cancers. For diagnosis year 1997 and onward, the MCR 
conducts “death clearance” to identify cases of cancer reported on death certificates which had 
not been reported to the MCR.  The MCR obtains additional information on these cases through 
follow-up activities with hospitals, nursing homes and physicians’ offices.  For some cases, 
however, the death certificate is the only source of information. From 1997 to 1999, there was 
just one child who was identified only through information from the death certificate. 
 
Childhood cancer is rare and typically requires treatment by pediatric oncology specialists who 
are overwhelmingly connected with tertiary centers and teaching hospitals. When treatment or 
diagnostic tests are conducted in outpatient facilities, these facilities are usually attached to a 
hospital.  Therefore, the MCR data collection system should be capturing the majority of 
childhood cancers statewide. 
 
Since diagnosis year 1995, each year the North American Association of Central Cancer 
Registries (NAACCR) reviews cancer registry data for quality, completeness, and timeliness.  
For diagnosis year 1997-1999, the MCR’s total case count was estimated by the NAACCR to be 
complete and the MCR was awarded a gold certificate by the NAACCR for quality, complete, 
and timely data.   
 
The Massachusetts incidence data summarized in this report were drawn from data entered on 
MCR computer files before February 2002.  The numbers may change slightly in future reports 
due to late reported cases or corrections based on subsequent details from the reporting facilities. 
Data in this report include invasive cancers diagnosed from 1990 to 1999 among Massachusetts 
residents less than 20 years old (children 0-14 years and adolescents 15-19 years). Case reports 
for 1990 were coded following the International Classification of Diseases for Oncology, First 
Edition (ICD-O-1) system and then converted to the International Classification of Diseases for 
Oncology, Second Edition (ICD-O-2) system. Case reports for 1991-1999 were coded following 
the ICD-O-2 system.  All of the cases were grouped into ICCC categories.  The ICCC system 
groups ICD-O-2 morphology (form or structure) and topography (site) codes into 12 major 
categories (4) (Appendix I).  Although the ICCC includes some tumors of benign or uncertain 
behavior in its classification of central nervous system and intracranial and intraspinal 
neoplasms, those tumors are not included in this report.  The Massachusetts data include invasive 
cancers only. 
 
The national childhood cancer incidence data are from the National Cancer Institute’s 
Surveillance, Epidemiology, and End Results (SEER) program.  The SEER program includes 
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data from population-based cancer registries in 18 states and geographic areas, covering 
approximately 26% of the United States population. Unless otherwise noted, the SEER incidence 
data presented in this report are from 9 SEER areas during 1990 to 1999 among males and 
females 0-19 years old. Data from the 3 supplemental SEER registries and the 6 SEER registries 
that began collecting data after 1990 are not included in this report.  The data are for malignant 
cancers only and have been categorized by the ICCC.  The national incidence data were obtained 
from the SEER 1973-1999 public-use data (5) using the SEER*Stat 4.2.6 software. 
 
Cancer Mortality 
 
Massachusetts childhood cancer death data are from the Massachusetts Registry of Vital Records 
and Statistics, which has legal responsibility for collecting reports of deaths.  Death reports from 
1990 to 1998 were coded using the International Classification of Diseases, Ninth Revision 
(ICD-9).  Data in this report include cancer deaths from 1990 to 1998 among Massachusetts 
residents less than 20 years of age (children 0-14 years and adolescents 15-19 years).  Although 
more recent death data are available, they have been coded using the International Classification 
of Diseases, Tenth Revision (ICD-10).    Only death data through 1998 are included in this report 
so that data collected with similar coding are combined or compared over time.  
 
The national childhood cancer mortality data are based on data from the National Center for 
Health Statistics. Unless otherwise noted, the national mortality data presented in this report are 
for males and females 0-19 years old who died between 1990 and 1998.  The national mortality 
data were obtained from the SEER 1973-1999 public-use data (5) using the SEER*Stat 4.2.6 
software. 
 
 
Statistical Calculations 
 
Age-adjusted incidence and mortality rates presented in this report were calculated by the direct 
method to correct for differences in the age distributions of different populations.  Age-adjusted 
rates were calculated by weighting the age-specific rates within five-year age groups during a 
given period by the age distribution of a standard population.  The weighted age-specific rates 
were then added to produce the adjusted rate for all ages combined.  The 2000 U.S. population 
distribution was used as the standard.  The age-adjusted rates are presented as rates per 100,000 
population.  Rates can only be compared if they have been adjusted to the same standard.  Age-
adjusted cancer incidence and mortality rates presented in this report may differ from those in 
other reports which used a different standard such as the 1940 or 1970 U.S. population.  
 
Age-specific rates are specific for a particular age range.  The age-specific rates in this report 
were calculated by dividing the number of people in an age group who were diagnosed with 
cancer or died of cancer in a given time frame by the number of people in that same age group 
overall in a given time frame.  The age-specific rates are presented as rates per 100,000. 
 
For the computation of Massachusetts incidence and mortality rates in this report, the statewide 
population for individual years is based on population estimates released by the Massachusetts 
Institute for Social and Economic Research (MISER) in September, 2000.  Rates are not 
calculated if the number of cases is less than 5 because they are unstable. 
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The estimated annual percent change (EAPC) is used to examine trends over time.  In this report, 
the EAPC was calculated based on methods from the National Cancer Institute’s SEER program 
(6).  The EAPC was calculated by fitting a regression line ln(r) = mx + b, where ln(r) is the 
natural logarithm of the rates, x is the year, and m is the slope of the line, and then using the 
equation EAPC = 100(em – 1).   A positive EAPC is indicative of an increasing trend, while a 
negative EAPC is indicative of a decreasing trend.  The EAPC assumes that the change in rate is 
the same over the entire time period examined, which may or may not be true for the trends 
examined in this report.  All of the EAPCs calculated in this report were tested against the 
hypothesis that they are equal to zero.  A p value ≤ 0.05 was used to determine statistical 
significance. 
 
The race/ethnicity categories presented in this report are mutually exclusive.  Cases and deaths 
are only included in one race/ethnicity category.  Individuals of Hispanic ethnicity are not 
included in a race group.  The race/ethnicity categories are white, non-Hispanic; black, non-
Hispanic; Asian/Pacific Islander, non-Hispanic; and Hispanic.  American Indians/Aleutians/ 
Eskimos are not included as a race/ethnicity category because of the small number of cases of 
childhood cancer among this group. 
 
 
Data Limitations 
 
When interpreting the cancer data, it is important to consider certain limitations.  These 
limitations include: under-reporting in areas close to neighboring states, potentially misleading 
trends, small numbers of cases, and misclassification and/or under-reporting of race/ethnicity 
data.  Although the MCR has reciprocal reporting agreements with fifteen states, including all 
New England states, there may still be loss of cases in Massachusetts residents who were 
diagnosed in neighboring states and not reported to the MCR. Apparent increases or decreases in 
cancer incidence over time may reflect changes in diagnostic methods or case reporting rather 
than true changes in cancer occurrence. Many of the calculations in this report involved small 
numbers of cases.  As a result, the data should be interpreted with caution.  Finally, data on 
race/ethnicity are based on information existing in the medical record for cancer cases and 
information on the death certificate for cancer deaths.   Errors in these source documents may 
lead to incorrect classification of race/ethnicity.  Also, some race/ethnicity categories may be 
under-reported since race/ethnicity is not available for all cases.  Counts and rates presented may 
under-represent the true incidence in some race/ethnic populations. 
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STATEWIDE PATTERNS OF CHILDHOOD CANCER INCIDENCE 
 
Overview 
 
During 1990-1999, 2,688 cases of invasive cancer were diagnosed in Massachusetts among 
children and adolescents less than 20 years old, approximately 270 cases per year.  About 53% 
of these childhood cancers occurred in males and 47% in females. The average annual age-
adjusted incidence rate of childhood cancer in Massachusetts during 1990-1999 was 16.7 cases 
per 100,000.  This combined rate is slightly higher than the national incidence rate of childhood 
cancer in the SEER areas during 1990-1999 of 16.1 per 100,000.  In Massachusetts, the age-
adjusted incidence rate of childhood cancer was higher for males than females, 17.4 cases per 
100,000 males and 16.1 cases per 100,000 females. 
 
Trends 
 
From 1990 to 1999, the age-adjusted incidence rate of childhood cancer did not increase or 
decrease greatly for either Massachusetts males or females (Figure 1).  The age-adjusted 
incidence rate of cancer for Massachusetts males was 16.0 cases per 100,000 males in 1990 and 
17.0 cases per 100,000 males in 1999.  The estimated annual percent change (EAPC) during this 
time period showed a decreasing trend of -0.7% per year for childhood cancer among males.  For 
Massachusetts females, the age-adjusted incidence rate of cancer was 14.7 cases per 100,000 
females in 1990 and 15.9 cases per 100,000 females in 1999, and the EAPC showed an 
increasing trend of 1.6% per year from 1990 to 1999.  However, neither the EAPC for males nor 
for females was statistically significant.  Data from the SEER program indicate that nationally, 
from 1975 to 1995, there were no large increases or decreases in the incidence of the major 
cancers among children less than 15 years old (7).  
 
Figure 1:  Trends in cancer incidence among children and adolescents less than 20 years 
old, Massachusetts, 1990-1999 
  * Age-adjusted to the 2000 U.S. Standard Population. 
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Most Common Types 
 
According to the ICCC diagnostic groupings, the three most common cancers among all 
Massachusetts children and adolescents less than 20 years old from 1990 to 1999 were leukemia, 
central nervous system cancers, and lymphomas (Appendix III).  These three cancers accounted 
for 60% of childhood cancer in males and 53% of childhood cancer in females.  No other 
grouping accounted for more than 10% of childhood cancer in either sex, except for carcinomas 
and other malignant epithelial neoplasms among females (Figure 2). 
 
 
Figure 2:  Distribution of cancer incidence among children and adolescents less than 20 
years old, Massachusetts, 1990-1999 
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Age Patterns 
 
The age-specific incidence rate of childhood cancer was highest among Massachusetts males and 
females 0-4 years old and 15-19 years old from 1990 to 1999 (Figure 3). 
 
 
Figure 3:  Age-specific incidence rates of childhood cancer by sex, Massachusetts, 1990-
1999 
 
 
In Massachusetts from 1990 to 1999, the most commonly occurring childhood cancer groupings 
varied by age group and sex (Figure 4). For Massachusetts males and females combined, 
leukemia was the most commonly diagnosed cancer grouping among 0-4 year olds and 5-9 year 
olds during 1990 to 1999. Central nervous system cancers was the most common cancer 
diagnostic group for all those 10-14 years old, and lymphomas was the most common cancer 
diagnostic group for all those 15-19 years old (Appendix IV). 
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Figure 4:  Age-specific incidence rates of leading childhood cancers by age group and sex, 
Massachusetts, 1990-1999 
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Race/Ethnicity Patterns 
 
Among Massachusetts children and adolescents less than 20 years old from 1995 to 1999, black, 
non-Hispanics and Hispanics had higher overall age-adjusted incidence rates of cancer than 
white, non-Hispanics and Asian/Pacific Islander, non-Hispanics (Figure 5).  During this time 
period, the age-adjusted incidence rate was 19.6 cases per 100,000 for black, non-Hispanic 
children and adolescents and 19.7 cases per 100,000 for Hispanic children and adolescents.  The 
Massachusetts Cancer Registry did not collect reliable race/ethnicity data before 1995.  It 
should be noted that many of the calculations in this report involve small numbers of cases.  
The differences in the rates may be due to chance, and the data should be interpreted with 
caution. 
 
 
Figure 5:  Age-adjusted* incidence rates of cancer among children and adolescents less 
than 20 years old by race/ethnicity, Massachusetts, 1995-1999 
* Age-adjusted to the 2000 U.S. Standard Population 
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SITE-SPECIFIC PATTERNS OF CHILDHOOD CANCER INCIDENCE 
 
LEUKEMIA 
 
Overview 
 
Leukemia is a group of cancers that develop in the blood-forming tissues.  Leukemia was the 
most commonly occurring cancer among both Massachusetts males and females less than 20 
years old during 1990-1999, accounting for over 20% of childhood cancers in each sex.  
Between 1990 and 1999, 339 cases of childhood leukemia were diagnosed among males and 282 
cases were diagnosed among females in the state.  During that time period, the age-adjusted 
incidence rate of leukemia among Massachusetts children and adolescents less than 20 years old 
was slightly higher for males than females, with 4.1 per 100,000 for males and 3.5 per 100,000 
for females. The incidence rate of childhood leukemia in Massachusetts was similar to the 
national incidence rate based on SEER data for males, females, and total (Table 1). 
 
 
Table 1:  Age-adjusted incidence rates* of leukemia among children and adolescents less 
than 20 years old, Massachusetts and SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 4.1 4.3 
Females 3.5 3.5 
Total 3.8 3.9 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Trends 
 
Between 1990 and 1999, the incidence rate of leukemia among Massachusetts children and 
adolescents less than 20 years old increased slightly, from 3.1 cases per 100,000 in 1990 to 4.1 
cases per 100,000 in 1999 (Figure 6).  The estimated annual percent change (EAPC) for 
leukemia from 1990 to 1999 was 3.0% per year, reflecting an increasing, though not statistically 
significant, trend in childhood leukemia in the state during that time period.   
 
Nationally, the incidence of leukemia among children under age 15 years increased abruptly 
from 1983 to 1984 by 22%.  However, there has been a slight decrease in the national incidence 
rate of leukemia among children under age 15 years since 1989 (7). 
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Figure 6:  Leukemia incidence trends among children and adolescents less than 20 years 
old, Massachusetts, 1990-1999 
  * Age-adjusted to the 2000 U.S. Standard Population. 
 
 
Age Patterns 
 
Between 1990 and 1999, the incidence rate of childhood leukemia was highest among 
Massachusetts males and females 0-4 years old, with 7.5 cases per 100,000 males and 7.0 cases 
per 100,000 females (Figure 7).  The incidence rate of leukemia was lower among the other age 
groups. 
 
 
Figure 7:  Age-specific incidence rates of leukemia by sex and age group, Massachusetts, 
1990-1999 
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Most Common Types 
 
Of all the leukemia occurring between 1990 and 1999 among Massachusetts children and 
adolescents less than 20 years old, 78% were lymphoid leukemias, 15% were acute non-
lymphocytic leukemias, and 3% were chronic myeloid leukemias (Figure 8). 
 
 
Figure 8:  Distribution of leukemia among children and adolescents less than 20 years old 
by ICCC subgroup, Massachusetts, 1990-1999 
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LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS 
 
Overview 
 
Lymphomas are cancers that develop from the lymphatic or reticuloendothelial (lymphocyte 
supporting tissue) system, the system of the body that helps fight infection and disease.  
Lymphomas were the second most commonly occurring childhood cancers among Massachusetts 
males and the fourth most commonly occurring childhood cancers among Massachusetts females 
between 1990 and 1999.  During this time period, lymphomas and other reticuloendothelial 
neoplasms accounted for about 19% of all cancers occurring among Massachusetts males less 
than 20 years old and 14% of all cancers occurring among Massachusetts females less than 20 
years old.  Between 1990 and 1999, 266 cases of childhood lymphoma were diagnosed among 
males and 175 cases were diagnosed among females in the state.  The age-adjusted incidence 
rate of lymphoma among children and adolescents less than 20 years old was higher for males 
than for females, 3.3 per 100,000 for males and 2.3 per 100,000 for females. The incidence rate 
of childhood lymphomas in Massachusetts was slightly higher than the national incidence rate 
based on SEER data for males, females, and total (Table 2). 
 
 
Table 2:  Age-adjusted incidence rates* of lymphomas among children and adolescents less 
than 20 years old, Massachusetts and SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 3.3 2.7 
Females 2.3 2.0 
Total 2.8 2.3 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Trends 
 
Between 1990 and 1999, the incidence rate of lymphomas among Massachusetts children and 
adolescents less than 20 years old fluctuated between 1.6 and 3.5 cases per 100,000  (Figure 9). 
The incidence rate of childhood lymphomas among Massachusetts children and adolescents was 
2.8 cases per 100,000 in 1990 and 2.5 cases per 100,000 in 1999.  The estimated annual percent 
change (EAPC) for childhood lymphomas in Massachusetts from 1990 to 1999 was 1.0% per 
year, a slight increasing trend, though the trend was not statistically significant.   
 
Nationally, the incidence of lymphoma among children under age 15 years decreased from 1975 
to 1995.  This decrease was statistically significant and was primarily due to a decline in the 
incidence of Hodgkin’s disease (7). 
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Figure 9:  Lymphomas incidence trends among children and adolescents less than 20 years 
old, Massachusetts, 1990-1999 
* Age-adjusted to the 2000 U.S. Standard Population. 
 
 
Age Patterns 
 
The incidence rate of childhood lymphomas was highest among Massachusetts adolescents 15-
19 years old, with 6.6 cases per 100,000 males and 5.4 cases per 100,000 females between 1990 
and 1999.  During this time period, the incidence rate of childhood lymphoma increased with 
increasing age group. Between 1990 and 1999, Massachusetts males had a higher incidence rate 
of childhood lymphomas than females in every age group (Figure 10). 
 
 
Figure 10:  Age-specific incidence rates of lymphomas by sex and age group, 
Massachusetts, 1990-1999 
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Most Common Types 
 
Of all the lymphomas occurring between 1990 and 1999 among Massachusetts children and 
adolescents less than 20 years old, over 50% were Hodgkin’s disease and 32% were non-
Hodgkin’s lymphoma (Figure 11). 
 
 
Figure 11:  Distribution of lymphomas among children and adolescents less than 20 years 
old by ICCC subgroup, Massachusetts, 1990-1999 
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CENTRAL NERVOUS SYSTEM AND MISCELLANEOUS INTRACRANIAL AND 
INTRASPINAL NEOPLASMS 
 
Overview 
 
Central nervous system and miscellaneous intracranial and intraspinal neoplasms (CNS tumors) 
include tumors that arise from the brain, spinal cord, and other sites within the skull and spinal 
cord.  These tumors were the third most commonly occurring childhood cancers among 
Massachusetts males and the second most commonly occurring childhood cancers among 
Massachusetts females between 1990 and 1999.  CNS tumors accounted for 17% of childhood 
cancer in both Massachusetts males and females.  Between 1990-1999, 249 childhood CNS 
tumors were diagnosed among males and 211 cases were diagnosed among females in the state.  
During this time period, the age-adjusted incidence rate of CNS tumors among Massachusetts 
children and adolescents less than 20 years old was slightly higher for males than females, 3.1 
per 100,000 for males and 2.7 per 100,000 for females. The incidence rate of childhood CNS 
tumors in Massachusetts was similar to the national incidence rate based on SEER data for 
males, females, and total (Table 3). 
 
 
Table 3:  Age-adjusted incidence rates* of CNS tumors among children and adolescents 
less than 20 years old, Massachusetts and SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 3.1 3.2 
Females 2.7 2.6 
Total 2.9 2.9 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Trends 
 
Between 1990 and 1999, the incidence rate of CNS tumors among Massachusetts children and 
adolescents less than 20 years old fluctuated between a low of 2.4 cases per 100,000 in 1990 and 
1994 and a high of 3.3 cases per 100,000 in 1999 (Figure 12).  The estimated annual percent 
change (EAPC) for CNS tumors from 1990 to 1999 was 1.5% per year, reflecting a slight 
increasing, though not statistically significant, trend in childhood CNS tumors in the state during 
that time period.   
 
Nationally, the incidence of brain and other CNS cancers among children under age 15 years 
increased from 1983 to 1986 by 55%, but has remained stable since that time through 1995.  It 
has been hypothesized that the increases in the mid 1980s may have been due to better diagnostic 
technology, such as magnetic resonance imaging, new surgical procedures, and classification 
changes (7). 
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Figure 12:  Incidence trends of CNS tumors among children and adolescents less than 20 
years old, Massachusetts, 1990-1999 
* Age-adjusted to the 2000 U.S. Standard Population. 
 
 
Age Patterns 
 
Among Massachusetts children and adolescents less than 20 years old, the incidence rate of CNS 
tumors from 1990 to 1999 was lowest among males and females 15-19 years old, at 2.0 cases per 
100,000 males and 1.5 cases per 100,000 females.  The incidence rates of childhood CNS tumors 
were more similar among the other age groups (Figure 13). 
 
 
Figure 13:  Age-specific incidence rates of CNS tumors by sex and age group, 
Massachusetts, 1990-1999 
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Most Common Types 
 
Of all the CNS tumors occurring between 1990 and 1999 among Massachusetts children and 
adolescents less than 20 years old, 49% were astrocytomas and 24% were primitive 
neuroectodermal tumors (Figure 14). 
 
 
Figure 14:  Distribution of CNS tumors among children and adolescents less than 20 years 
old by ICCC subgroup, Massachusetts, 1990-1999 
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SYMPATHETIC NERVOUS SYSTEM TUMORS 
 
Overview 
 
The sympathetic nervous system (SNS) is part of the autonomic nervous system, which regulates 
involuntary activities of the heart muscle, smooth muscle, and glands.  Between 1990 and 1999, 
tumors of the SNS accounted for about 7% of all cancers occurring among Massachusetts males 
and females less than 20 years old.  During this time period, 174 SNS tumors were diagnosed 
among children and adolescents in the state (93 in males and 81 in females).  The age-adjusted 
incidence rate of SNS tumors among Massachusetts children and adolescents less than 20 years 
old was 1.1 per 100,000 for males and 1.0 per 100,000 for females from 1990 to 1999. The 
incidence rate of childhood SNS tumors in Massachusetts was similar to the national incidence 
rate based on SEER data for males, females, and total (Table 4).  
 
 
Table 4:  Age-adjusted incidence rates* of SNS tumors among children and adolescents less 
than 20 years old, Massachusetts and SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 1.1 0.9 
Females 1.0 0.8 
Total 1.0 0.8 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Trends 
 
Between 1990 and 1999, the age-adjusted incidence rate of SNS tumors among Massachusetts 
children and adolescents less than 20 years old showed minor year to year fluctuations, but the 
rate was 0.8 cases per 100,000 in both 1990 and 1999 (Figure 15).  The estimated annual percent 
change (EAPC) for childhood SNS tumors in Massachusetts during this time period was -1.6% 
per year, a slight decreasing trend.  This trend was not statistically significant. 
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Figure 15:  Incidence trends of SNS tumors among children and adolescents less than 20 
years old, Massachusetts, 1990-1999 
* Age-adjusted to the 2000 U.S. Standard Population. 
 
 
Age Patterns 
 
The incidence rate of childhood SNS tumors from 1990 to 1999 was highest among 
Massachusetts children 0-4 years old, with 3.6 cases per 100,000.  About 86% of newly 
diagnosed cases of childhood SNS tumors occurred among children in this age group.  From 
1990 to 1999, the incidence rate of SNS tumors was less than 0.4 cases per 100,000 in all of the 
Massachusetts age groups between 5 and 19 years old (Figure 16). 
 
 
Figure 16:  Age-specific incidence rates of SNS tumors by age group, Massachusetts, 1990-
1999 
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Most Common Types 
 
Of all the SNS tumors occurring between 1990 and 1999 among Massachusetts children and 
adolescents less than 20 years old, 98% were neuroblastomas or ganglioneuroblastomas and the 
remainder were other SNS tumors.   
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RETINOBLASTOMA 
 
Overview 
 
Retinoblastoma is a cancer of the eye that occurs among very young children (2).  About 40% of 
cases of retinoblastoma are due to inherited mutations (changes) in a retinoblastoma related 
gene.  The remaining 60% of cases of retinoblastoma result from sporadic (random) mutations in 
a gene (8). 
 
Retinoblastoma was one of the least commonly occurring cancers among Massachusetts children 
and adolescents less than 20 years old between 1990 and 1999, accounting for only 1.8% of all 
childhood cancers in the state. During this time period, 49 cases of retinoblastoma were 
diagnosed among children and adolescents in the state.  The age-adjusted incidence rate of 
retinoblastoma among Massachusetts children and adolescents less than 20 years old was 0.3 per 
100,000 for males and 0.2 per 100,000 for females from 1990-1999. The incidence rate of 
childhood retinoblastoma in Massachusetts was similar to the national incidence rate based on 
SEER data for males, females, and total (Table 5). 
 
 
Table 5:  Age-adjusted incidence rates* of retinoblastoma among children and adolescents 
less than 20 years old, Massachusetts and SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 0.3 0.3 
Females 0.2 0.4 
Total 0.3 0.3 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Age Patterns 
 
In Massachusetts, over 95% of newly diagnosed cases of childhood retinoblastoma from 1990 to 
1999 occurred among children 0-4 years old. 
 
 
 
 
Note that no graphs are presented for childhood retinoblastoma because of the small number of 
cases.
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RENAL TUMORS 
 
Overview 
 
Between 1990 and 1999, renal (kidney) tumors accounted for just under 5% of all cancers 
occurring among Massachusetts males and females less than 20 years old.  During this time 
period, 121 cases of renal tumor were diagnosed among children and adolescents in the state.  
Between 1990-1999, the age-adjusted incidence rate of childhood renal tumors was the same for 
Massachusetts females and males, 0.7 cases per 100,000. The incidence rate of childhood renal 
tumors in Massachusetts was the same as the national incidence rate based on SEER data for 
males, females, and total (Table 6). 
 
 
Table 6:  Age-adjusted incidence rates* of renal tumors among children and adolescents 
less than 20 years old, Massachusetts and SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 0.7 0.7 
Females 0.7 0.7 
Total 0.7 0.7 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Trends 
 
Between 1990 and 1999, the incidence rate of renal tumors among Massachusetts children and 
adolescents less than 20 years old fluctuated between 0.4 and 1.3 cases per 100,000.  The 
incidence rate of childhood renal tumors was 0.5 cases per 100,000 in both 1990 and 1999 
(Figure 17).  The estimated annual percent change (EAPC) for childhood renal tumors in 
Massachusetts from 1990 to 1999 was  –2.2% per year, a slight decreasing trend.  This trend was 
not statistically significant. 
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Figure 17:  Incidence trends of renal tumors among children and adolescents less than 20 
years old, Massachusetts, 1990-1999 
* Age-adjusted to the 2000 U.S. Standard Population. 
 
 
Age Patterns 
 
Among Massachusetts children and adolescents less than 20 years old, children 0-4 years old had 
the highest incidence rate of renal tumors from 1990 to 1999, with 2.1 cases per 100,000 (Figure 
18). 
 
 
Figure 18:  Age-specific incidence rates of renal tumors by age group, Massachusetts, 1990-
1999 
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Most Common Types 
 
Of all the renal tumors occurring between 1990 and 1999 among Massachusetts children and 
adolescents, 91% were Wilms’ tumor, rhabdoid and clear cell sarcoma, 8% were renal 
carcinoma, and the remainder were unspecified malignant renal tumors.  Wilms’ tumors, 
rhabdoid and clear cell sarcomas occurred most commonly among children less than 5 years old, 
with 79% of these cases occurring among these children. 
 
Genetic factors have been linked to Wilms’ tumor, and children with Wilms’ tumor may have 
other congenital defects.  There are several syndromes that include Wilms’ tumor, including the 
Beckwith-Wiedemann syndrome, the Denys-Drash syndrome, and the WAGR syndrome (8).  
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HEPATIC TUMORS 
 
Overview  
 
Hepatic (liver) tumors were the least commonly occurring cancers among Massachusetts 
children and adolescents less than 20 years old between 1990 and 1999.  They accounted for 
only 1.5% of all childhood cancers in the state. During this time period, 40 cases of hepatic 
tumors were diagnosed among children and adolescents in the state.  The age-adjusted incidence 
rate of hepatic tumors among Massachusetts children and adolescents less than 20 years old was 
similar for males and females, 0.3 per 100,000 for males and 0.2 per 100,000 for females from 
1990-1999.  The incidence rate of childhood hepatic tumors in Massachusetts was similar to the 
national incidence rate based on SEER data for males, females, and total (Table 7).   
 
 
Table 7:  Age-adjusted incidence rates* of hepatic tumors among children and adolescents 
less than 20 years old, Massachusetts and SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 0.3 0.2 
Females 0.2 0.2 
Total 0.2 0.2 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Age Patterns 
 
Among Massachusetts children and adolescents less than 20 years old, 65% of newly diagnosed 
cases of hepatic tumors from 1990 to 1999 occurred among children 0-4 years old.   
 
Most Common Types 
 
Of all the hepatic tumors occurring during that time period among Massachusetts children and 
adolescents, 63% were hepatoblastomas, 35% were hepatic carcinomas, and the remainder were 
unspecified malignant hepatic tumors. 
 
 
 
 
Note that no graphs are presented for childhood hepatic tumors because of the small number of 
cases. 
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MALIGNANT BONE TUMORS 
 
Overview  
 
Between 1990 and 1999, malignant bone tumors accounted for about 5% of all cancers occurring 
among Massachusetts children and adolescents less than 20 years old.  During this time period, 
137 malignant bone tumors were diagnosed among children and adolescents in the state.  The 
age-adjusted incidence rate of malignant bone tumors among Massachusetts children and 
adolescents less than 20 years old was similar for males and females, 1.0 per 100,000 for males 
and 0.8 per 100,000 for females, from 1990-1999. The incidence rate of childhood malignant 
bone tumors in Massachusetts was similar to the national incidence rate based on SEER data for 
males, females, and total (Table 8). 
 
 
Table 8:  Age-adjusted incidence rates* of malignant bone tumors among children and 
adolescents less than 20 years old, Massachusetts and SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 1.0 1.1 
Females 0.8 0.7 
Total 0.9 0.9 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Trends 
 
Between 1990 and 1999, the incidence rate of malignant bone tumors among Massachusetts 
children and adolescents less than 20 years old fluctuated between 0.6 and 1.3 cases per 100,000 
and hovered around 1 case per 100,000 each year (Figure 19).  The estimated annual percent 
change (EAPC) for childhood bone tumors was fairly stable, with a 0.5% increase per year.  The 
EAPC was not statistically significant. 
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Figure 19:  Incidence trends of malignant bone tumors among children and adolescents less 
than 20 years old, Massachusetts, 1990-1999 
* Age-adjusted to the 2000 U.S. Standard Population. 
 
 
Age Patterns 
 
Between 1990 and 1999 in Massachusetts, the incidence rate of malignant bone tumors was 
higher in children 10-14 years old and adolescents 15-19 years old than in children 0-4 and 5-9 
years old.  During this time period, 10-14 year olds in Massachusetts had an age-specific 
incidence rate of malignant bone tumors of 1.5 cases per 100,000 and 15-19 year olds had an 
age-specific incidence rate of 1.6 cases per 100,000 (Figure 20). 
 
 
Figure 20:  Age-specific incidence rates of malignant bone tumors by age group, 
Massachusetts, 1990-1999 
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Most Common Types 
 
Of all the malignant bone tumors occurring between 1990 and 1999 among Massachusetts 
children and adolescents less than 20 years old, 66% were osteosarcomas and 27% were Ewing’s 
sarcomas (Figure 21). 
 
 
Figure 21:  Distribution of malignant bone tumors among children and adolescents less 
than 20 years old by ICCC subgroup, Massachusetts, 1990-1999 
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SOFT-TISSUE SARCOMAS 
 
Overview  
 
Soft-tissue sarcomas are cancers that develop in the supporting tissues, such as muscle, fat, and 
blood vessels.  Between 1990 and 1999, soft-tissue sarcomas accounted for about 7% of 
childhood cancer in Massachusetts, 9% for males and 6% for females.  During this time period, 
122 childhood soft-tissue sarcomas were diagnosed among males and 77 cases were diagnosed 
among females in the state.  The age-adjusted incidence rate of soft-tissue sarcomas among 
Massachusetts children and adolescents less than 20 years old was slightly higher for males than 
females, 1.5 per 100,000 for males and 1.0 per 100,000 for females from 1990-1999.  The 
incidence rate of childhood soft-tissue sarcomas in Massachusetts was slightly higher than the 
national incidence rate based on SEER data for males, but was similar to the national rate for 
females and total (Table 9). 
 
 
Table 9:  Age-adjusted incidence rates* of soft-tissue sarcomas among children and 
adolescents less than 20 years old, Massachusetts and SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 1.5 1.2 
Females 1.0 1.1 
Total 1.2 1.1 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Trends 
 
Between 1990 and 1999, the incidence rate of soft-tissue sarcomas among Massachusetts 
children and adolescents less than 20 years old fluctuated between 0.6 and 1.8 cases per 100,000 
(Figure 22). The incidence rate of childhood soft-tissue sarcomas was 1.6 cases per 100,000 in 
1990 and 1.5 cases per 100,000 in 1999.  The estimated annual percent change (EAPC) for 
childhood soft-tissue sarcomas in Massachusetts from 1990 to 1999 was –2.4% per year, a slight 
decreasing, though not statistically significant, trend.   
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Figure 22:  Incidence trends of soft-tissue sarcomas among children and adolescents less 
than 20 years old, Massachusetts, 1990-1999 
* Age-adjusted to the 2000 U.S. Standard Population. 
 
 
Age Patterns 
 
The incidence rate of childhood soft-tissue sarcomas from 1990 to 1999 was highest among 
Massachusetts males 15-19 years old, with 2.1 cases per 100,000.  For Massachusetts females, 
the incidence rate of childhood soft-tissue sarcomas was highest for those 0-4 and 10-14 years 
old during that time period, with 1.2 and 1.1 cases per 100,000 respectively.  Between 1990 and 
1999, Massachusetts males had a higher incidence rate of childhood soft-tissue sarcoma than 
females in every age group (Figure 23). 
 
 
Figure 23:  Age-specific incidence rates of soft-tissue sarcomas by sex and age group, 
Massachusetts, 1990-1999 
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Most Common Types 
 
Of all the soft-tissue sarcomas occurring between 1990 and 1999 among Massachusetts children 
and adolescents less than 20 years old, approximately 42% were rhabdomyosarcomas and 
embryonal sarcomas and 21% were fibrosarcomas, neurofibrosarcomas and other fibromatous 
neoplasms (Figure 24). 
 
 
Figure 24:  Distribution of soft-tissue sarcomas among children and adolescents less than 
20 years old by ICCC subgroup, Massachusetts, 1990-1999 
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GERM CELL, TROPHOBLASTIC AND OTHER GONADAL NEOPLASMS 
 
Overview 
 
Germ cell (egg or sperm), trophoblastic (cells outside an early embryo) and other gonadal 
(ovarian or testicular) neoplasms arise from reproductive cells.  Between 1990 and 1999, germ 
cell, trophoblastic  and other gonadal neoplasms accounted for about 7% of all cancers occurring 
among Massachusetts children and adolescents less than 20 years old.  During this time period, 
175 germ cell, trophoblastic and other gonadal neoplasms were diagnosed among children and 
adolescents in the state (90 in males and 85 in females).  The age-adjusted incidence rate of germ 
cell, trophoblastic and other gonadal neoplasms among Massachusetts children and adolescents 
less than 20 years old was the same for males and females, 1.1 per 100,000, from 1990-1999. 
The incidence rate of childhood germ cell, trophoblastic and other gonadal neoplasms in 
Massachusetts was similar to the national incidence rate based on SEER data for males, females, 
and total (Table 10). 
 
 
Table 10:  Age-adjusted incidence rates* of germ cell, trophoblastic and other gonadal 
neoplasms among children and adolescents less than 20 years old, Massachusetts and 
SEER areas, 1990-1999 
 Massachusetts SEER areas
Males 1.1 1.3 
Females 1.1 1.1 
Total 1.1 1.2 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Trends 
 
Except for a slight deviation in 1995, the age-adjusted incidence rate of germ cell, trophoblastic 
and other gonadal neoplasms among Massachusetts children and adolescents less than 20 years 
old was about 1 case per 100,000 from 1990 to 1999 (Figure 25).  The estimated annual percent 
change (EAPC) for these childhood cancers was 1.6% per year from 1990 to 1999, a slight 
increasing trend.  This trend, however, was not statistically significant. 
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Figure 25:  Incidence trends of germ cell, trophoblastic and other gonadal neoplasms 
among children and adolescents less than 20 years old, Massachusetts, 1990-1999 
* Age-adjusted to the 2000 U.S. Standard Population. 
 
 
Age Patterns 
 
Between 1990 and 1999, Massachusetts adolescents 15-19 years old had the highest incidence 
rates of childhood germ cell, trophoblastic and other gonadal neoplasms, with 2.9 and 2.1 cases 
per 100,000 males and females, respectively (Figure 26). 
 
 
Figure 26:  Age-specific incidence rates of germ cell, trophoblastic and other gonadal 
neoplasms by sex and age group, Massachusetts, 1990-1999 
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Of all the germ cell, trophoblastic and other gonadal neoplasms occurring between 1990 and 
1999 among Massachusetts children and adolescents less than 20 years old, 59% were gonadal 
germ cell tumors (Figure 27). 
 
 
Figure 27:  Distribution of germ cell, trophoblastic and other gonadal neoplasms among 
children and adolescents less than 20 years old by ICCC subgroup, Massachusetts, 1990-
1999 
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CARCINOMAS AND OTHER MALIGNANT EPITHELIAL NEOPLASMS 
 
Overview  
 
Carcinomas are many different cancers that develop from epithelial cells that form the lining of 
organs.  Between 1990 and 1999, carcinomas and other malignant epithelial neoplasms were the 
third most commonly occurring cancers among Massachusetts females, accounting for about 15% 
of childhood cancer among females in the state.  During this time period, only 74 cases of 
childhood carcinomas and other malignant epithelial neoplasms were diagnosed among males, 
compared to 183 cases diagnosed among females in the state.  Between 1990 and 1999, the age-
adjusted incidence rate of carcinomas and other malignant epithelial neoplasms among 
Massachusetts children and adolescents less than 20 years old was higher for females than for 
males, 0.9 per 100,000 for males and 2.4 per 100,000 for females. The incidence rate of childhood 
carcinomas and other malignant epithelial neoplasms in Massachusetts was similar to the national 
incidence rate based on SEER data for males and total, but was slightly higher than the national 
rate for females (Table 11). 
 
 
Table 11:  Age-adjusted incidence rates* of carcinomas and other malignant epithelial 
neoplasms among children and adolescents less than 20 years old, Massachusetts and 
SEER areas, 1990-1999 
 
 Massachusetts SEER areas
Males 0.9 1.0 
Females 2.4 2.1 
Total 1.6 1.5 
*per 100,000.  Age-adjusted to the 2000 U.S. Standard Population 
 
 
Trends 
 
Between 1990 and 1999, the age-adjusted incidence rate of carcinomas and other malignant 
epithelial neoplasms among Massachusetts children and adolescents less than 20 years old 
fluctuated between 1.1 and 2.5 cases per 100,000 (Figure 28). The incidence rate of childhood 
carcinomas and other malignant epithelial neoplasms was 1.2 cases per 100,000 in 1990 and 1.3 
cases per 100,000 in 1999.  These childhood neoplasms showed a slightly decreasing trend and 
an estimated annual percent change (EAPC) of -2.6% per year from 1990 to 1999.  Again, this 
trend was not statistically significant. 
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Figure 28:  Incidence trends of carcinomas and other malignant epithelial neoplasms 
among children and adolescents less than 20 years old, Massachusetts, 1990-1999 
* Age-adjusted to the 2000 U.S. Standard Population. 
 
 
Age Patterns 
 
In Massachusetts between 1990 and 1999, females had a higher age-specific incidence rate of 
carcinomas and other malignant epithelial neoplasms than males for most age groups less than 
20 years old.  For both Massachusetts males and females less than 20 years old, the age-specific 
incidence rate of carcinomas and other malignant epithelial neoplasms was highest among those 
15-19 years old.  Massachusetts females in this age group had the highest incidence of childhood 
carcinomas and other malignant epithelial neoplasms from 1990 to 1999, with 6.7 cases per 
100,000 (Figure 29). 
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Figure 29:  Age-specific incidence rates of carcinomas and other malignant epithelial 
neoplasms by sex and age group, Massachusetts, 1990-1999 
 
 
Most Common Types 
 
Of all the carcinomas and other malignant epithelial neoplasms occurring between 1990 and 
1999 among Massachusetts children and adolescents less than 20 years old, 30% were thyroid 
carcinomas and 23% were melanomas (Figure 30).  About 78% of the childhood thyroid 
carcinomas and 58% of the childhood malignant melanomas occurred among females. 
 
 
Figure 30:  Distribution of carcinomas and other malignant epithelial neoplasms among 
children and adolescents less than 20 years old by ICCC subgroup, Massachusetts, 1990-
1999 
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 STATEWIDE PATTERNS OF CHILDHOOD CANCER MORTALITY 
 
Overview  
 
In Massachusetts in 1998, cancer was the second leading cause of death among children aged 1-
14 years (9). During 1990-1998, 394 Massachusetts children and adolescents less than 20 years 
old died of cancer, approximately 40 deaths per year.  About 61% of these childhood cancer 
deaths occurred in males and 39% in females. The average annual age-adjusted mortality rate of 
childhood cancer in Massachusetts during 1990-1998 was 2.8 deaths per 100,000. This mortality 
rate is slightly lower than the national mortality rate of childhood cancer during 1990-1998 of 
3.1 per 100,000.  In Massachusetts, the age-adjusted childhood cancer mortality rate was higher 
for males than females, 3.3 deaths per 100,000 males vs. 2.2 deaths per 100,000 females. 
 
Trends 
 
From 1990 to 1998, the age-adjusted mortality rate of childhood cancer decreased slightly for 
Massachusetts children and adolescents less than 20 years old (Figure 31).  The age-adjusted 
mortality rate of childhood cancer was 2.7 deaths per 100,000 in 1990 and 2.1 deaths per 
100,000 in 1998. During this time period, the estimated annual percent change (EAPC) for 
cancer mortality was -3.2% per year, reflecting a decreasing trend in childhood cancer mortality 
in Massachusetts from 1990 to 1998.  This trend was not statistically significant.  Similarly, 
mortality rates decreased nationally from 1975 to 1995 for all major cancer categories among 
children under age 15 years due to improvements in treatment and survival (7). 
 
 
Figure 31:  Trends in cancer mortality among children and adolescents less than 20 years 
old, Massachusetts, 1990-1998 
* Age-adjusted to the 2000 U.S. Standard Population. 
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Most Common Causes  
 
The four most common causes of cancer death among Massachusetts children and adolescents 
less than 20 years old from 1990 to 1998 were leukemias, followed by cancers of the brain & 
central nervous system and bone, and then lymphomas.  During this time period, the age-
adjusted mortality rate of each of these cancers overall was less than 1 per 100,000 (Appendix 
V).  The top four causes of childhood cancer death in Massachusetts accounted for 68% of 
childhood cancer deaths in males and 65% of childhood cancer deaths in females.  No other 
specific cancer site accounted for more than 4% of childhood cancer deaths in either sex (Figure 
32). 
 
 
Figure 32:  Distribution of cancer mortality among children and adolescents less than 20 
years old, Massachusetts, 1990-1998 
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Age Patterns 
 
From 1990 to 1998, Massachusetts males had a higher age-specific mortality rate of childhood 
cancer than females for each age group.  For both males and females, the highest mortality rates 
of childhood cancer were among those 15-19 years old (Figure 33). 
 
 
Figure 33:  Age-specific mortality rates of childhood cancer by age group and sex, 
Massachusetts, 1990-1998 
 
 
Race/Ethnicity Patterns 
 
Black, non-Hispanics had the highest overall age-adjusted cancer mortality rate among 
Massachusetts children and adolescents from 1990 to 1998, followed by Asian/Pacific Islander, 
non-Hispanics (Figure 34).  During this time period, the age-adjusted mortality rate was 3.6 
deaths per 100,000 for black, non-Hispanic children and adolescents and 3.1 deaths per 100,000 
for Asian/Pacific Islander, non-Hispanic children and adolescents.  White, non-Hispanic and 
Hispanic children and adolescents both had age-adjusted cancer mortality rates of 2.7 deaths per 
100,000 from 1990 to 1998.  However, it should be noted that many of the calculations in 
this report involve small numbers of cases.  The differences in the rates may be due to 
chance, and the data should be interpreted with caution. 
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Figure 34:  Age-adjusted* mortality rates of cancer among children and adolescents less 
than 20 years old by race/ethnicity, Massachusetts, 1990-1998  
  * Age-adjusted to the 2000 U.S. Standard Population 
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Appendix I 
International Classification of Childhood Cancer* 
 
 ICD-O-2** codes 
ICCC Diagnostic Group Morphology Topography 
I. Leukemia   
 a. Lymphoid leukemia 9820-9827, 9850  
 b. Acute non-lymphocytic leukemia 9840, 9841, 9861, 9864, 9866, 
9867, 9891, 9894, 9910 
 
 c. Chronic myeloid leukemia 9863, 9868  
 d. Other specified leukemias 9830, 9842, 9860, 9862, 9870-
9890, 9892, 9893, 9900, 9930-
9941 
 
 e. Unspecified leukemias 9800-9804  
II. Lymphomas and 
Reticuloendothelial Neoplasms 
  
 a. Hodgkin’s disease 9650-9667  
 b. Non-Hodgkin’s lymphoma 9591-9595, 9670-9686, 9690-
9714, 9723 
 
 c. Burkitt’s lymphoma 9687  
 d. Miscellaneous lymphoreticular 
neoplasms 
9720, 9731-9764  
 e. Unspecified lymphomas 9590  
III. Central Nervous System and 
Miscellaneous Intracranial and 
Intraspinal Neoplasms 
  
 a. Ependymoma 9383, 9390-9394  
 b. Astrocytoma 9380 C72.3 
 9381, 9400-9441  
 c. Primitive neuroectodermal tumors 9470-9473  
 d. Other gliomas 9380 
 
C70.0-C72.2, 
C72.4-C72.9 
 9382, 9384  
 9442-9460, 9481  
 e. Other specified intracranial and 
intraspinal neoplasms 
8270-8281, 8300, 9350-9362, 
9480, 9505, 9530-9539 
 
 f. Unspecified intracranial and 
intraspinal neoplasms 
8000-8004 C70.0-C72.9, 
C75.1-C75.3 
                                                
* Chart from: Kramárová E, Stiller CA, Ferlay J, Parkin DM, Draper GJ, Michaelis J, Neglia J, Qureshi S (eds).  
International Classification of Childhood Cancer 1996. International Agency for Research on Cancer, International 
Association of Cancer Registries, International Society of Paediatric Oncology.  IARC Technical Report No. 29.  
Lyon, France, 1996. 
** International Classification of Diseases for Oncology, 2nd Ed.  
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IV. Sympathetic Nervous System 
Tumors 
  
 a. Neuroblastoma and 
ganglioneuroblastoma 
9490, 9500  
 b. Other sympathetic nervous 
system tumors 
8680, 8693-8710, 9501-9504, 
9520-9523 
 
V. Retinoblastoma 9510-9512  
VI. Renal Tumors   
 a. Wilms’ tumor, rhabdoid and clear 
cell sarcoma 
8960, 8964 
 
 
 
 8963 C64.9, C80.9 
 b. Renal carcinoma 8010-8041, 8050-8075, 8082, 
8120-8122, 8130-8141, 8143, 
8155, 8190-8201, 8210, 8211, 
8221-8231, 8240, 8241, 8244-
8246, 8260-8263, 8290, 8310, 
8320, 8323, 8401, 8430, 8440, 
8480-8490, 8504, 8510, 8550, 
8560-8573 
C64.9 
 8312  
 c. Unspecified malignant renal 
tumors 
8000-8004 C64.9 
VII. Hepatic Tumors   
 a. Hepatoblastoma 8970  
 b. Hepatic carcinoma 8010-8041, 8050-8075, 8082, 
8120-8122, 8140, 8141, 8143, 
8155, 8910-8201, 8210, 8211, 
8230, 8231, 8240, 8241, 8244-
8246, 8260-8263, 8310, 8320, 
8323, 8401, 8430, 8440, 8480-
8490, 8504, 8510, 8550, 8560-
8573 
C22.0, C22.1 
 8160-8180  
 c. Unspecified malignant hepatic 
tumors 
8000-8004 C22.0, C22.1 
VIII. Malignant Bone Tumors   
 a. Osteosarcoma 9180-9200  
 b. Chondrosarcoma 9220-9230  
 9231, 9240 C40.0-C41.9 
 c. Ewing’s sarcoma 9260 C40.0-C41.9, 
C80.9 
 9363, 9364 C40.0-C41.9 
 d. Other specified malignant bone 
tumors 
8812, 9250, 9261-9330, 9370  
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 e. Unspecified malignant bone 
tumors 
8000-8004, 8800, 8801, 8803, 
8804 
C40.0-C41.9 
 
IX. Soft-Tissue Sarcomas   
 a. Rhabdomyosarcoma and 
embroyonal sarcoma 
8900-8920, 8991  
 b. Fibrosarcoma, neurofibrosarcoma 
and other fibromatous neoplasms 
8810, 8811, 8813-8833, 9540-
9561 
 
 c. Kaposi’s sarcoma 9140  
 d. Other specified soft-tissue 
sarcomas 
8840-8896, 8982, 8990, 9040-
9044, 9120-9134, 9150-9170, 
9251, 9581 
 
 8963 C00.0-C63.9, 
C65.9-C76.8 
 9231, 9240, 9363, 9364 C00.0-C39.9, 
C47.0-C80.9 
 9260 C00.0-C39.9, 
C47.0-C76.8 
 e. Unspecified soft-tissue sarcomas 8800-8804 C00.0-C39.9, 
C44.0-C80.9 
X. Germ Cell, Trophoblastic and 
Other Gonadal Neoplasms 
  
 a. Intracranial and intraspinal germ 
cell tumors 
9060-9102 C70.0-C72.9, 
C75.1-C75.3 
 b. Other and unspecified non-
gonadal germ cell tumors 
9060-9102 C00.0-C55.9, 
C57.0-C61.9, 
C63.0-C69.9, 
C73.9-C75.0, 
C75.4-C80.9 
 c. Gonadal germ cell tumors 9060-9102 C56.9, 
C62.0-C62.9 
 d. Gonadal carcinomas 8010-8041, 8050-8075, 8082, 
8120-8122, 8130-8141, 8143, 
8155, 8190-8201, 8210, 8211, 
8221-8241, 8244-8246, 8260-
8263, 8290, 8310, 8320, 8323, 
8430, 8440, 8480-8490, 8504, 
8510, 8550, 8560-8573 
C56.9, 
C62.0-C62.9 
 8380, 8381, 8441-8473  
 e. Other and unspecified malignant 
gonadal tumors 
8590-8670, 9000  
 8000-8004 C56.9, 
C62.0-C62.9 
XI. Carcinomas and Other Malignant 
Epithelial Neoplasms 
  
 a. Adrenocortical carcinoma 8370-8375  
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 b. Thyroid carcinoma 8010-8041, 8050-8075, 8082, 
8120-8122, 8130-8141, 8155, 
8190, 8200, 8201, 8211, 8230, 
8231, 8244-8246, 8260-8263, 
8290, 8310, 8320, 8323, 8430, 
8440, 8480, 8481, 8500-8573 
C73.9 
 8330-8350  
 c. Nasopharyngeal carcinoma 8010-8041, 8050-8075, 8082, 
8120-8122, 8130-8141, 8155, 
8190, 8200, 8201, 8211, 8230, 
8231, 8244-8246, 8260-8263, 
8290, 8310, 8320, 8323, 8430, 
8440, 8480, 8481, 8504, 8510, 
8550, 8560-8573 
C11.0-C11.9 
 d. Malignant melanoma 8720-8780  
 e. Skin carcinoma 8010-8041, 8050-8075, 8082, 
8090-8110, 8140, 8143, 8147, 
8190, 8200, 8240, 8246, 8247, 
8260, 8310, 8320, 8323, 8390-
8420, 8430, 8480, 8542, 8560, 
8570-8573, 8940 
C44.0-C44.9 
 f. Other and unspecified carcinomas 8010-8082, 8120-8155, 8190-
8263, 8290, 8310, 8314-8323, 
8430-8440, 8480-8580, 8940, 
8941 
C00.0-C10.9, 
C12.9-C21.8, 
C23.9-C39.9, 
C48.0-C48.8, 
C50.0-C55.9, 
C57.0-C61.9, 
C63.0-C63.9, 
C65.9-C72.9, 
C75.0-C80.9 
XII. Other and Unspecified Malignant 
Neoplasms 
  
 a. Other specified malignant tumors 8930, 8933, 8950, 8951, 8971-
8981, 9020, 9050-9053, 9110, 
9580 
 
 b. Other unspecified malignant 
tumors 
8000-8004 C00.0-C21.8, 
C23.9-C39.9, 
C42.0-C55.9, 
C57.0-C61.9, 
C63.0-C63.9, 
C65.9-C69.9, 
C73.9-C75.0, 
C75.4-C80.9 
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Appendix II 
ICD-9 Codes* 
 
 
 
Cancer site/type 
 
 
ICD-9 code 
 
Bone 
 
 
170 
 
Brain & Central Nervous System 
 
 
191-192 
 
Kidney 
 
 
189.0-189.1 
 
Leukemia 
 
 
204-208 
 
Liver 
 
 
155 
 
Lymphoma 
 
 
200, 201, 202.0-202.2, 
202.8-202.9 
 
 
Melanoma/Skin 
 
 
172-173 
 
Thyroid 
 
 
193 
 
 
                                                
* International Classification of Diseases, Ninth Revision, Clinical Modification  
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Appendix III
CHILDHOOD1 CANCER INCIDENCE BY SEX
Massachusetts, 1990-1999
 Males Females T o t a l 
ICCC Diagnostic Group 2 Number Percent Rate 3 Number Percent Rate 3 Number Percent Rate 3
All Groups 1427 100.0 17.4 1261 100.0 16.1 2688 100.0 16.7
Leukemia 339 23.8 4.1 282 22.4 3.5 621 23.1 3.8
Lymphomas and Reticuloendothelial 
Neoplams 266 18.6 3.3 175 13.9 2.3 441 16.4 2.8
Central Nervous System and Miscellaneous 
Intracranial and Intraspinal Neoplasms 249 17.4 3.1 211 16.7 2.7 460 17.1 2.9
Sympathetic Nervous System Tumors 93 6.5 1.1 81 6.4 1.0 174 6.5 1.0
Retinoblastoma 29 2.0 0.3 20 1.6 0.2 49 1.8 0.3
Renal Tumors 63 4.4 0.7 58 4.6 0.7 121 4.5 0.7
Hepatic Tumors 23 1.6 0.3 17 1.3 0.2 40 1.5 0.2
Malignant Bone Tumors 77 5.4 1.0 60 4.8 0.8 137 5.1 0.9
Soft-Tissue Sarcomas 122 8.5 1.5 77 6.1 1.0 199 7.4 1.2
Germ Cell, Trophoblastic and Other Gonadal 
Neoplasms 90 6.3 1.1 85 6.7 1.1 175 6.5 1.1
Carcinomas and Other Malignant Epithelial 
Neoplasms 74 5.2 0.9 183 14.5 2.4 257 9.6 1.6
Other and Unspecified Malignant Neoplasms 2 0.1 * 12 1.0 0.2 14 0.5 0.1
1 children and adolescents less than 20 years old
2 Kramarova E et al.  (eds).  International Classification of Childhood Cancer 1996.  IARC, IACR, SIOP.  IARC Technical Report No. 29.  Lyon, France, 1996.
3 per 100,000; age-adjusted to the 2000 U.S. Standard Population
* age-adjusted incidence rate not calculated when number of cases < 5   
Appendix IV
AGE-SPECIFIC INCIDENCE RATES1 OF CHILDHOOD CANCER  BY SEX
Massachusetts, 1990-1999
 0-4 years 5-9 years 10-14 years 15-19 years
ICCC Diagnostic Group 2 Males Females Total Males Females Total Males Females Total Males Females Total
All Groups 23.1 20.1 21.6 13.0 10.1 11.6 12.7 14.0 13.3 21.1 20.2 20.7
Leukemia 7.5 7.0 7.3 4.0 3.1 3.5 2.4 2.3 2.4 2.6 1.9 2.2
Lymphomas and Reticuloendothelial 
Neoplams 1.2 0.6 0.9 2.5 0.7 1.6 3.0 2.3 2.6 6.6 5.4 6.0
Central Nervous System and Miscellaneous 
Intracranial and Intraspinal Neoplasms 3.8 3.4 3.6 3.5 2.8 3.2 3.0 3.2 3.1 2.0 1.5 1.7
Sympathetic Nervous System Tumors 3.7 3.5 3.6 0.3 0.3 0.3 * * 0.2 * * 0.1
Retinoblastoma 1.4 0.9 1.1 * * * * * * * * *
Renal Tumors 2.2 2.0 2.1 0.5 0.6 0.5 * * * * 0.3 0.2
Hepatic Tumors 0.7 0.6 0.6 * * * * * * 0.2 * 0.2
Malignant Bone Tumors * * * * 0.5 0.3 1.4 1.7 1.5 2.2 1.0 1.6
Soft-Tissue Sarcomas 1.5 1.2 1.4 1.2 0.7 1.0 1.2 1.1 1.2 2.1 0.9 1.5
Germ Cell, Trophoblastic and Other Gonadal 
Neoplasms 0.9 0.3 0.6 * 0.9 0.5 0.5 1.1 0.8 2.9 2.1 2.5
Carcinomas and Other Malignant Epithelial 
Neoplasms * 0.4 0.3 0.5 0.4 0.4 0.8 1.9 1.4 2.2 6.7 4.4
Other and Unspecified Malignant Neoplasms * * * * * * * * * * 0.3 0.1
1 per 100,000
2 Kramarova E et al.  (eds).  International Classification of Childhood Cancer 1996.  IARC, IACR, SIOP.  IARC Technical Report No. 29.  Lyon, France, 1996.
* age-specific incidence rate not calculated when number of cases < 5   
Appendix V
CHILDHOOD1 CANCER MORTALITY BY SEX
Massachusetts, 1990-1998
 Males Females T o t a l 
Cancer Site / Type Number Percent Rate 2 Number Percent Rate 2 Number Percent Rate 2
All Sites 242 100.0 3.3 152 100.0 2.2 394 100.0 2.8
Bone 17 7.0 0.2 12 7.9 0.2 29 7.4 0.2
Brain & Central Nervous System 51 21.1 0.7 27 17.8 0.4 78 19.8 0.5
Kidney 4 1.7 * 6 3.9 0.1 10 2.5 0.1
Leukemia 80 33.1 1.1 53 34.9 0.8 133 33.8 0.9
Liver 5 2.1 0.1 3 2.0 * 8 2.0 0.1
Lymphoma 16 6.6 0.2 7 4.6 0.1 23 5.8 0.2
Melanoma/Skin 3 1.2 * 3 2.0 * 6 1.5 0.0
Thyroid 0 0.0 * 1 0.7 * 1 0.3 *
Other Sites 66 27.3 - - - 40 26.3 - - - 106 26.9 - - -
1 children and adolescents less than 20 years old
2 per 100,000; age-adjusted to the 2000 U.S. Standard Population
* age-adjusted mortality rate not calculated when number of cases < 5   
